HIGHLIGHTS
- who: Gul Ambreen et al. from the Department of Pharmacy, Aga Khan University Hospital, Karachi, Pakistan, Department of Paediatrics and have published the article: Evaluation of pharmaceutically compounded oral caffeine on the impact of medication adherence and risk of readmission among preterm neonates: A single-center quasi-experimental study, in the Journal: PLOS ONE of 11/03/2022
- what: The aim of this study was to assess the association between the pharmaceutically compounded oral caffeine (PCC) use in preterm neonates and the therapy-related factors (e_g safety and efficacy of therapy length and complexity of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.